 |
|
|
| |
Gender Stratification Analysis of HIV-1 Infected Patients Receiving Atazanavir (ATV) Compared to ATV/Ritonavir (RTV), Each in Combination With Abacavir/Lamivudine (ABC/3TC), After Initial Suppression With ABC/3TC + ATV/RTV Through 144 Weeks on Therapy
|
| |
| |
Reported by Jules Levin
52nd ICAAC Sept 9-12 2012 SF
K Squires, MD,1B Young,2L Santiago,3R Dretler,4S Walmsley,5H Zhao,6B Wine,6LL Ross,6M Shaefer7
1Jefferson Medical College, Philadelphia, PA; 2Apex Research, Denver, CO; International Association of Physicians in AIDS Care, Washington, DC; 3HOPE Clinical Research, San Juan, Puerto Rico; 4ID Specialists of Atlanta, Decatur, GA; 5University Health Network, Toronto, Canada; 6GlaxoSmithKline, Research Triangle Park, NC; 7ViiV Healthcare, Research Triangle Park, NC
References
1. Squires KE, Young B, DeJesus E, et al. HIV Clin Trials. 2010;11(2):69-79.
2. Squires KE, Young B, DeJesus E, et al. AIDS. 2010;24(13):2019-2027.
3. Centers for Disease Control and Prevention.
http://www.cdc.gov/hiv/surveillance/resources/reports/2007report/table16.htm. Accessed May 1, 2012.
|
| |
|
|
|
|
|
